M Haynes

Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study

Rachael A Evans, Olivia C. Leavy, Matthew Richardson et al. · The Lancet Respiratory Medicine · 2022 · 424 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +16

SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

Felicity Liew, Shubha Talwar, Andy Cross et al. · EBioMedicine · 2022 · 121 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +11

CUS1, a suppressor of cold-sensitive U2 snRNA mutations, is a novel yeast splicing factor homologous to human SAP 145.

Sandra E. Wells, Megan C. Neville, M Haynes et al. · Genes & Development · 1996 · 67 citations · Full text

Life Sciences, Genetics, Molecular Biology +14

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Amr E. Abbas, Fatima Abbas et al. · The Lancet Diabetes & Endocrinology · 2023 · 40 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +11

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

Saul N. Faust, Richard Haynes, Christine E. Jones et al. · The Lancet Child & Adolescent Health · 2024 · 38 citations · Full text

Life Sciences, Immunology, Pediatrics +15